NCT02628210View on ClinicalTrials.gov

Interbody Spacers With map3® Cellular Allogeneic Bone Graft in Anterior or Lateral Lumbar Interbody Fusion

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
SpondylosisSpondylolisthesisDegenerative Disc Disease
Interventions
OTHER

map3® Cellular Allogeneic Bone Graft

Patients will receive map3® Cellular Allogeneic Bone Graft

Trial Locations (3)

14221

AXIS Neurosurgery and Spine of WNY, PLLC, Williamsville

14304

Spine Surgery of Buffalo Niagara, LLC, Niagara Falls

45219

Carl & Edyth Lindner Center for Research The Christ Hospital, Cincinnati

Sponsors

Lead Sponsor

RTI Surgical
All Listed Sponsors
lead

RTI Surgical

INDUSTRY